Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
![Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology](https://www.cannabisindustry.news/wp-content/uploads/2022/08/CannabisIndustryNews_Favicon002.png)
FAST Nanoemulsion Technology Expected to be a Competitive Advantage for Organigrams Ingestible Portfolio
TORONTO Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of can…